Cristina Suárez
Universitat Autònoma de Barcelona(ES)Universidad de Oviedo(ES)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Renal and related cancers, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma(2021)1,675 cited
- → Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma(2018)1,227 cited
- → Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial(2019)994 cited
- → Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial(2019)560 cited
- → Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial(2020)489 cited